Exploring the role of routine brain imaging in detecting asymptomatic brain metastases in first diagnosed HER2-positive breast cancer
This study found limited benefit in routine MRI for detecting asymptomatic brain metastases in HER2-positive breast cancer, given the low prevalence (3.6%). A targeted imaging approach for high-risk patients, like those with the absence of Hormon receptors and higher stage tumors, may be effective.
Authors
- Carmen Leser (ORCID: https://orcid.org/0000-0002-5230-4853)
- Olgica Zaric (ORCID: https://orcid.org/0000-0003-4577-3392)
- Daphne Gschwantler‐Kaulich (ORCID: https://orcid.org/0000-0002-7401-0987)
- Christine Deutschmann (ORCID: https://orcid.org/0000-0003-0427-0051)
- Georg Dorffner (ORCID: https://orcid.org/0000-0002-3181-2576)
- Fiona Kabashi
Institutions
- Danube Private University (AT)
- Universität für Weiterbildung Krems (AT)
- Austrian Research Institute for Artificial Intelligence (AT)
- Karl Landsteiner Society (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1371/journal.pone.0334610
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00